Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>PMBCL R/R* > TREAT > Co: USA. G. Axicabtagene Ciloleucel

---

Co: USA. G. Axicabtagene Ciloleucel's subsections
(*) EU Approval Date: 2018. 08.27.
CAR-T Therapy
Company
Generic N.: axicabtagene ciloleucel
Patent>Assignee; Claims; No.; Etc.
PMBCL:
TradeMark
TradeMark Web-Site

Co: USA. G. Axicabtagene Ciloleucel's products
This section has no products